Hexaminolevulinate hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for hexaminolevulinate hydrochloride and what is the scope of patent protection?
Hexaminolevulinate hydrochloride
is the generic ingredient in one branded drug marketed by Photocure Asa and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.Hexaminolevulinate hydrochloride has twenty-nine patent family members in seventeen countries.
One supplier is listed for this compound.
Summary for hexaminolevulinate hydrochloride
International Patents: | 29 |
US Patents: | 3 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 74 |
Clinical Trials: | 11 |
Patent Applications: | 246 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in hexaminolevulinate hydrochloride? | hexaminolevulinate hydrochloride excipients list |
DailyMed Link: | hexaminolevulinate hydrochloride at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for hexaminolevulinate hydrochloride
Generic Entry Date for hexaminolevulinate hydrochloride*:
Constraining patent/regulatory exclusivity:
Dosage:
FOR SOLUTION;INTRAVESICAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for hexaminolevulinate hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
KARL STORZ Endoscopy-America, Inc. | Phase 2 |
Dr. Te Vuong | Phase 2 |
Photocure | Phase 2/Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for hexaminolevulinate hydrochloride
US Patents and Regulatory Information for hexaminolevulinate hydrochloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Photocure Asa | CYSVIEW KIT | hexaminolevulinate hydrochloride | FOR SOLUTION;INTRAVESICAL | 022555-001 | May 28, 2010 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Photocure Asa | CYSVIEW KIT | hexaminolevulinate hydrochloride | FOR SOLUTION;INTRAVESICAL | 022555-001 | May 28, 2010 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Photocure Asa | CYSVIEW KIT | hexaminolevulinate hydrochloride | FOR SOLUTION;INTRAVESICAL | 022555-001 | May 28, 2010 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for hexaminolevulinate hydrochloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Photocure Asa | CYSVIEW KIT | hexaminolevulinate hydrochloride | FOR SOLUTION;INTRAVESICAL | 022555-001 | May 28, 2010 | ⤷ Try a Trial | ⤷ Try a Trial |
Photocure Asa | CYSVIEW KIT | hexaminolevulinate hydrochloride | FOR SOLUTION;INTRAVESICAL | 022555-001 | May 28, 2010 | ⤷ Try a Trial | ⤷ Try a Trial |
Photocure Asa | CYSVIEW KIT | hexaminolevulinate hydrochloride | FOR SOLUTION;INTRAVESICAL | 022555-001 | May 28, 2010 | ⤷ Try a Trial | ⤷ Try a Trial |
Photocure Asa | CYSVIEW KIT | hexaminolevulinate hydrochloride | FOR SOLUTION;INTRAVESICAL | 022555-001 | May 28, 2010 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for hexaminolevulinate hydrochloride
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
United Kingdom | 201522309 | ⤷ Try a Trial | |
Spain | 2910034 | ⤷ Try a Trial | |
Russian Federation | 2745194 | СПОСОБ ФОТОДИНАМИЧЕСКОЙ ТЕРАПИИ (ФДТ) ДЛЯ РАКА МОЧЕВОГО ПУЗЫРЯ (METHOD OF PHOTODYNAMIC THERAPY (PDT) OF BLADDER CANCER) | ⤷ Try a Trial |
Australia | 2016372573 | Neoadjuvant therapy for bladder cancer | ⤷ Try a Trial |
China | 108697800 | 用于膀胱癌的光动力疗法(PDT)的方法 (METHOD OF PHOTODYNAMIC THERAPY (PDT) FOR BLADDER CANCER) | ⤷ Try a Trial |
Australia | 2016372575 | Method of photodynamic therapy (PDT) for bladder cancer | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |